Literature DB >> 2982880

Distribution of fibronectin and laminin in human liver tumors.

M Szendröi, K Lapis.   

Abstract

Two extracellular matrix and basement-membrane components, fibronectin (Fn) and laminin, were studied by the indirect immunoperoxidase technique in ten primary human liver cancers. Similar distributions of both Fn and laminin were detected in the well differentiated hepatocellular carcinomas with trabecular and tubular pattern. Two moderately differentiated hepatomas contained Fn only. Neither Fn nor laminin were present, however, in the parenchyma of one poorly differentiated hepatoma. In three cases of cholangiocarcinoma, laminin surrounded the tumorous ducts, while Fn appeared mainly in the reactive connective tissue stroma. The present findings indicate that bile-duct cancers synthesize laminin, and not Fn while differentiated hepatocellular carcinomas produce both Fn and laminin in vivo. The presence of Fn even in moderately differentiated types of liver cancer is in contrast to the findings for carcinomas developing from other organs and it may serve as a marker for primary hepatocellular carcinomas in the differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982880     DOI: 10.1007/bf01884256

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  17 in total

1.  Laminin--a glycoprotein from basement membranes.

Authors:  R Timpl; H Rohde; P G Robey; S I Rennard; J M Foidart; G R Martin
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

2.  Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus.

Authors:  A Vaheri; E Ruoslahti
Journal:  Int J Cancer       Date:  1974-05-15       Impact factor: 7.396

3.  Primary cultures of rat hepatocytes synthesize fibronectin.

Authors:  B Voss; S Allam; J Rauterberg; K Ullrich; V Gieselmann; K von Figura
Journal:  Biochem Biophys Res Commun       Date:  1979-10-29       Impact factor: 3.575

4.  Properties of a basement membrane-related glycoprotein synthesized in culture by a mouse embryonal carcinoma-derived cell line.

Authors:  A E Chung; R Jaffe; I L Freeman; J P Vergnes; J E Braginski; B Carlin
Journal:  Cell       Date:  1979-02       Impact factor: 41.582

5.  Laminin and fibronectin in cell adhesion: enhanced adhesion of cells from regenerating liver to laminin.

Authors:  R Carlsson; E Engvall; A Freeman; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

Review 6.  Fibronectin: current concepts of its structure and functions.

Authors:  E Ruoslahti; E Engvall; E G Hayman
Journal:  Coll Relat Res       Date:  1981

7.  Synthesis of fibronectin, laminin, and several collagens by a liver-derived epithelial line.

Authors:  J M Foidart; J J Berman; L Paglia; S Rennard; S Abe; A Perantoni; G R Martin
Journal:  Lab Invest       Date:  1980-05       Impact factor: 5.662

8.  Fibronectin in human hepatocellular carcinoma.

Authors:  M Isemura; Z Yosizawa; N Kojima; F Ichida
Journal:  Tohoku J Exp Med       Date:  1982-12       Impact factor: 1.848

9.  Distribution of basement membrane proteins in normal and fibrotic human liver: collagen type IV, laminin, and fibronectin.

Authors:  E Hahn; G Wick; D Pencev; R Timpl
Journal:  Gut       Date:  1980-01       Impact factor: 23.059

10.  Distribution of a major connective tissue protein, fibronectin, in normal human tissues.

Authors:  S Stenman; A Vaheri
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  4 in total

Review 1.  Cholangiocarcinoma 2020: the next horizon in mechanisms and management.

Authors:  Jesus M Banales; Jose J G Marin; Angela Lamarca; Pedro M Rodrigues; Shahid A Khan; Lewis R Roberts; Vincenzo Cardinale; Guido Carpino; Jesper B Andersen; Chiara Braconi; Diego F Calvisi; Maria J Perugorria; Luca Fabris; Luke Boulter; Rocio I R Macias; Eugenio Gaudio; Domenico Alvaro; Sergio A Gradilone; Mario Strazzabosco; Marco Marzioni; Cédric Coulouarn; Laura Fouassier; Chiara Raggi; Pietro Invernizzi; Joachim C Mertens; Anja Moncsek; Sumera Rizvi; Julie Heimbach; Bas Groot Koerkamp; Jordi Bruix; Alejandro Forner; John Bridgewater; Juan W Valle; Gregory J Gores
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-06-30       Impact factor: 46.802

2.  Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.

Authors:  H Okushin; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-02

3.  Serum fibronectin distinguishes the early stages of hepatocellular carcinoma.

Authors:  Hyunsoo Kim; JiYoung Park; Yongkang Kim; Areum Sohn; Injun Yeo; Su Jong Yu; Jung-Hwan Yoon; Taesung Park; Youngsoo Kim
Journal:  Sci Rep       Date:  2017-08-25       Impact factor: 4.379

4.  Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment.

Authors:  Sun Ah Kim; Eun Ju Cho; Sungyoung Lee; Young Youn Cho; Boram Kim; Jung-Hwan Yoon; Taesung Park
Journal:  Sci Rep       Date:  2020-12-04       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.